Role of Radiation in Combination With CD30-Directed Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Hodgkin Lymphoma

被引：0
|
作者：
Ladbury, Colton [1 ]
Hao, Claire [1 ]
Mei, Matthew [2 ]
Herrera, Alex [2 ]
Green, Garth [1 ]
Dandapani, Savita [1 ]
机构：
[1] City Of Hope, Dept Radiat Oncol, Natl Med Ctr, Duarte, CA 91010 USA
[2] City Of Hope, Dept Hematol & Hematopoiet Cell Transplantat, Natl Med Ctr, Duarte, CA USA
来源：
ADVANCES IN RADIATION ONCOLOGY | 2024年 / 9卷 / 04期
关键词：
PATTERNS;
D O I：
10.1016/j.adro.2023.101428
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
下载
收藏
页数：5
相关论文
共 50 条
  • [1] Anti-PD-1 Therapy Enhances the Efficacy of CD30-Directed Chimeric Antigen Receptor T Cell Therapy in Patients With Relapsed/Refractory CD30+Lymphoma
    Sang, Wei
    Wang, Xiangmin
    Geng, Hongzhi
    Li, Tianci
    Li, Dashan
    Zhang, Bingpei
    Zhou, Yi
    Song, Xuguang
    Sun, Cai
    Yan, Dongmei
    Li, Depeng
    Li, Zhenyu
    Li, Caixia
    Xu, Kailin
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [2] Chimeric Antigen Receptor T-Cell Therapy Targeting CD30 in Hodgkin Lymphoma
    Savoldo, Barbara
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (01) : 24 - 26
  • [3] CD30-Directed Chimeric Antigen Receptor (CAR)-T Cells for Treatment of Hodgkin Lymphoma and NonHodgkin Lymphoma in Pediatric Patients
    Hucks, George E., Jr.
    Savoldo, Barbara
    Dotti, Gianpietro
    Cheng, Catherine Joyce Arago
    Babinec, Caroline
    Kasow, Kimberly A.
    Winstead, Michael
    Patel, Arpita
    Presler, Cammie
    Grover, Natalie S.
    Morrison, J. Kaitlin
    Beaven, Anne W.
    Riches, Marcie L.
    Shea, Thomas C.
    Serody, Jonathan S.
    BLOOD, 2021, 138
  • [4] Induction Radiation Prior to Commercial Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Non-Hodgkin Lymphoma
    LaRiviere, M. J.
    Wright, C. M.
    Arscott, W. T.
    Miller, D.
    Weber, E.
    Landsburg, D. J.
    Svoboda, J.
    Nasta, S. D.
    Gerson, J. N.
    Chong, E. A.
    Schuster, S.
    Maity, A.
    Plastaras, J. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S66 - S66
  • [5] Anti-CD30 Chimeric Antigen Receptor T Cell Therapy for CD30+ Relapsed/Refractory Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma Patients
    Wang, Di
    Xiao, Yi
    Li, Chunrui
    Wang, Na
    Huang, Liang
    Zhang, Yicheng
    Zhang, Tongcun
    Zhou, Jianfeng
    BLOOD, 2018, 132
  • [6] Cardiovascular effects of chimeric antigen receptor t-cell therapy for refractory or relapsed non-hodgkin lymphoma
    Ganatra, S.
    Redd, R.
    Hayek, S.
    Parikh, R.
    Azam, T.
    Yanik, G.
    Spendley, L.
    Nikiforow, S.
    Jacobson, C.
    Nohria, A.
    EUROPEAN HEART JOURNAL, 2020, 41 : 3263 - 3263
  • [7] Role of radiation in chimeric antigen receptor T-cell therapy for patients with relapsed/refractory non-Hodgkin lymphoma: Current studies and future prospects
    Yu, Lingzi
    Zou, Rui
    He, Jiajie
    Qu, Changju
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 199
  • [8] Anti-CD30 chimeric antigen receptor T cell therapy for relapsed/refractory CD30+ lymphoma patients
    Wang, D.
    Zeng, C.
    Xu, B.
    Xu, J. -H.
    Wang, J.
    Jiang, L. -J.
    Wang, Q. -X.
    Li, C. -R.
    Wang, N.
    Huang, L.
    Zhang, Y. -C.
    Xiao, Y.
    Zhou, J. -F.
    BLOOD CANCER JOURNAL, 2020, 10 (01)
  • [9] Anti-CD30 chimeric antigen receptor T cell therapy for relapsed/refractory CD30+ lymphoma patients
    D. Wang
    C. Zeng
    B. Xu
    J.-H. Xu
    J. Wang
    L.-J. Jiang
    Q.-X. Wang
    C.-R. Li
    N. Wang
    L. Huang
    Y.-C. Zhang
    Y. Xiao
    J.-F. Zhou
    Blood Cancer Journal, 10
  • [10] Chimeric Antigen Receptor T-Cell Therapy in the Management of Relapsed Non-Hodgkin Lymphoma
    Komanduri, Krishna V.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (05) : 476 - +
12345